Print Print page | Email Email page      
    

Investor Relations

The investor pages that follow are your resource for financial information about Aastrom Biosciences, Inc.. In this section you will find information about our current and historical share price, analyst coverage, SEC filings, an electronic version of our annual report and frequently asked questions as well as forms to request additional information.

Recent Press Releases

03-09-10
Aastrom Announces Treatment of Final Patient in IMPACT-DCM Surgical Clinical Trial

03-04-10
Aastrom Regains Compliance With NASDAQ Minimum Bid Requirement

more »

Events

05-11-10
World Stem Cells & Regenerative Medicine Congress 2010

02-24-10
Conference Call to Discuss Interim Results from RESTORE-CLI Clinical Trial

more »



Stock Information
ASTMD - (NASDAQ)
$1.49   - 0.01
03-11-10
12:33 PM ET
Quotes delayed at least 20 minutes. Information provided by eSignal.

Shareholder Tools
Home | Forward Looking Statement Aastrom Biosciences, Inc. · Tel: 734-930-5555     © 2010